In a report released today, Joseph Pantginis from H.C. Wainwright reiterated a Buy rating on Rexahn Pharma (RNN – Research
Tag: Joseph Pantginis
Ligand Pharma (LGND) Receives a Buy from H.C. Wainwright
H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Ligand Pharma (LGND – Research Report) today and set a
H.C. Wainwright Sticks to Their Buy Rating for Xoma Corp (XOMA)
In a report released today, Joseph Pantginis from H.C. Wainwright reiterated a Buy rating on Xoma Corp (XOMA – Research
Checkpoint Therapeutics Inc (CKPT) Receives a Buy from H.C. Wainwright
In a report released today, Joseph Pantginis from H.C. Wainwright reiterated a Buy rating on Checkpoint Therapeutics Inc (CKPT –
H.C. Wainwright Keeps Their Buy Rating on Rigel (RIGL)
In a report released today, Joseph Pantginis from H.C. Wainwright reiterated a Buy rating on Rigel (RIGL – Research Report),
H.C. Wainwright Thinks Onconova Therapeutics’ Stock is Going to Recover
In a report released today, Joseph Pantginis from H.C. Wainwright reiterated a Buy rating on Onconova Therapeutics (ONTX – Research
Genocea Biosciences (GNCA) Receives a Buy from H.C. Wainwright
H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Genocea Biosciences (GNCA – Research Report) today and set a